Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
NCT03675022
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
9
Enrollment
OTHER
Sponsor class
Stopped
Inability to recruit during COVID
Conditions
Sleep Apnea
Rhinosinusitis Chronic
Interventions
DRUG:
Dupilumab
Sponsor
Brigham and Women's Hospital